Tenax Therapeutics, Inc. (NASDAQ:TENX)’s Basic Consolidated EPS Came In At $-0.5015

0

The annual basic consolidated EPS for Tenax Therapeutics, Inc. (NASDAQ:TENX) posted annual basic consolidated EPS of $-0.5015 for the year period ended2015-04-30. But basic consolidated EPS for the quarter period ended 2015-04-30 came in at $-0.5015.

What About EPS from continuing operations

Tenax Therapeutics, Inc. (NASDAQ:TENX)’s EPS from continuing operations for the annual period ended 2015-04-30 came in at -0.5015. On quarterly basis, EPS from continuing operations stood at $-0.5015 for the three-month period ended 2015-04-30.

EPS contribution from parent

Tenax Therapeutics, Inc. (NASDAQ:TENX) received of $-0.5015 EPS boost from the parent company for the annual period ended 2015-04-30. For the quarter period ended 2015-04-30, the company received EPS boost of $-0.5015 from its parent company.

What About Basic net EPS

The company’s basic net EPS for the annual period ended 2015-04-30 was$-0.5, but for the quarter period ended 2015-04-30 the basic net EPS was $-0.5.

What About Consolidated Diluted EPS?

Tenax Therapeutics, Inc. (NASDAQ:TENX) posted consolidated diluted EPS of $-0.5015 for the annual period ended 2015-04-30. On the other hand, consolidated diluted EPS for the quarterly period ended 2015-04-30 stood at $-0.5015.

Basic diluted EPS

The company’s diluted EPS from continuing operation stood at $-0.5015 for the annual period ended 2015-04-30. On quarter basis, diluted EPS from continuing operations was $-0.5015 for the three-month period ended 2015-04-30.

Net diluted EPS

Tenax Therapeutics, Inc. (NASDAQ:TENX) posted net diluted EPS of $-0.5for the annual period ended 2015-04-30. On the other hand, it posted net diluted EPS of $-0.5 for thequarterly period ended 2015-04-30.

What portion of diluted EPS came from parent?

For the annual period ended 2015-04-30, the parent company of Tenax Therapeutics, Inc. (NASDAQ:TENX) contributed diluted EPS of $-0.5015. The diluted EPS contribution from the parent for the quarter ended 2015-04-30 stood at $-0.5015.

The company’s net basic EPS for the annual period ended 2015-04-30 was $-0.5 while for the quarter period ended 2015-04-30 it was $-0.5.

Tenax Therapeutics, Inc. (NASDAQ:TENX) had average basic shares outstanding of 28.078 for the annual period ended 2015-04-30 and 28.078 for the quarter period ended 2015-04-30.The number of diluted shares outstanding was 28.078 for the annual period ended 2015-04-30 and 28.078 for the quarter ended 2015-04-30.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 22 times, 1 visits today)